Clinical Trial Update: Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of azacitidine in cancer patients with and without impaired renal function has completed. Results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Hodgkin Disease
• Multiple Myeloma
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma
• Solid Tumors

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Celgene | Conditions: MDS, AML | Phase 1 | Status: COMPLETED | Results posted: 2013-10-17